136 related articles for article (PubMed ID: 19468032)
1. A multicenter cohort study to compare quality of life in breast cancer patients according to sentinel lymph node biopsy or axillary lymph node dissection.
Dabakuyo TS; Fraisse J; Causeret S; Gouy S; Padeano MM; Loustalot C; Cuisenier J; Sauzedde JM; Smail M; Combier JP; Chevillote P; Rosburger C; Boulet S; Arveux P; Bonnetain F
Ann Oncol; 2009 Aug; 20(8):1352-61. PubMed ID: 19468032
[TBL] [Abstract][Full Text] [Related]
2. Impact of sentinel node biopsy on long-term quality of life in breast cancer patients.
De Gournay E; Guyomard A; Coutant C; Boulet S; Arveux P; Causeret S; Gouy S; Padeano MM; Loustalot C; Sauzedde JM; Smail M; Combier JP; Chevillote P; Rosburger C; Bonnetain F; Fraisse J; Dabakuyo-Yonli TS
Br J Cancer; 2013 Nov; 109(11):2783-91. PubMed ID: 24169352
[TBL] [Abstract][Full Text] [Related]
3. Quality-of-life impact of sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients.
Belmonte R; Garin O; Segura M; Pont A; Escalada F; Ferrer M
Value Health; 2012; 15(6):907-15. PubMed ID: 22999141
[TBL] [Abstract][Full Text] [Related]
4. Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients.
Peintinger F; Reitsamer R; Stranzl H; Ralph G
Br J Cancer; 2003 Aug; 89(4):648-52. PubMed ID: 12915872
[TBL] [Abstract][Full Text] [Related]
5. Impact of modern-day axillary treatment on patient reported arm morbidity and physical functioning in breast cancer patients.
Gregorowitsch ML; Verkooijen HM; Houweling A; Fuhler N; Koelemij R; Schoenmaeckers EJP; Sier MF; Ernst MF; Witkamp AJ; Van Dalen T; Young-Afat DA; van den Bongard DHJG;
Radiother Oncol; 2019 Feb; 131():221-228. PubMed ID: 30033384
[TBL] [Abstract][Full Text] [Related]
6. Quality of life after sentinel lymph node biopsy or axillary lymph node dissection in stage I/II breast cancer patients: a prospective longitudinal study.
Kootstra J; Hoekstra-Weebers JE; Rietman H; de Vries J; Baas P; Geertzen JH; Hoekstra HJ
Ann Surg Oncol; 2008 Sep; 15(9):2533-41. PubMed ID: 18597146
[TBL] [Abstract][Full Text] [Related]
7. Quality of life after sentinel lymph node biopsy versus complete axillary lymph node dissection in early breast cancer: a 3-year follow-up study.
Boguševičius A; Čepulienė D
Medicina (Kaunas); 2013; 49(3):111-7. PubMed ID: 23893054
[TBL] [Abstract][Full Text] [Related]
8. Time to deterioration in quality of life score as a modality of longitudinal analysis in patients with breast cancer.
Hamidou Z; Dabakuyo TS; Mercier M; Fraisse J; Causeret S; Tixier H; Padeano MM; Loustalot C; Cuisenier J; Sauzedde JM; Smail M; Combier JP; Chevillote P; Rosburger C; Arveux P; Bonnetain F
Oncologist; 2011; 16(10):1458-68. PubMed ID: 21948650
[TBL] [Abstract][Full Text] [Related]
9. Impact of axillary dissection in women with invasive breast cancer who do not fit the Z0011 ACOSOG trial because of three or more metastatic sentinel lymph nodes.
Bonneau C; Hequet D; Estevez JP; Pouget N; Rouzier R
Eur J Surg Oncol; 2015 Aug; 41(8):998-1004. PubMed ID: 25986854
[TBL] [Abstract][Full Text] [Related]
10. Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer.
Li J; Jia S; Zhang W; Qiu F; Zhang Y; Gu X; Xue J
BMC Surg; 2015 Jun; 15():79. PubMed ID: 26123412
[TBL] [Abstract][Full Text] [Related]
11. Self-perceived, but not objective lymphoedema is associated with decreased long-term health-related quality of life after breast cancer surgery.
Sackey H; Johansson H; Sandelin K; Liljegren G; MacLean G; Frisell J; Brandberg Y
Eur J Surg Oncol; 2015 Apr; 41(4):577-84. PubMed ID: 25659877
[TBL] [Abstract][Full Text] [Related]
12. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
[TBL] [Abstract][Full Text] [Related]
13. Arm morbidity of axillary dissection with sentinel node biopsy versus delayed axillary dissection.
Ballal H; Hunt C; Bharat C; Murray K; Kamyab R; Saunders C
ANZ J Surg; 2018 Sep; 88(9):917-921. PubMed ID: 29392828
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer.
Burak WE; Hollenbeck ST; Zervos EE; Hock KL; Kemp LC; Young DC
Am J Surg; 2002 Jan; 183(1):23-7. PubMed ID: 11869698
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node biopsy compared with axillary lymph node dissection in early breast cancer: a meta-analysis.
Wang Z; Wu LC; Chen JQ
Breast Cancer Res Treat; 2011 Oct; 129(3):675-89. PubMed ID: 21743996
[TBL] [Abstract][Full Text] [Related]
16. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
17. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial.
Del Bianco P; Zavagno G; Burelli P; Scalco G; Barutta L; Carraro P; Pietrarota P; Meneghini G; Morbin T; Tacchetti G; Pecoraro P; Belardinelli V; De Salvo GL;
Eur J Surg Oncol; 2008 May; 34(5):508-13. PubMed ID: 17614245
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of shoulder strength, shoulder range of motion, and lymphedema in breast cancer patients from pre-surgery to 5 years after ALND or SLNB.
Belmonte R; Messaggi-Sartor M; Ferrer M; Pont A; Escalada F
Support Care Cancer; 2018 Sep; 26(9):3277-3287. PubMed ID: 29651594
[TBL] [Abstract][Full Text] [Related]
19. Improved false negative rate of axillary status using sentinel lymph node biopsy and ultrasound-suspicious lymph node sampling in patients with early breast cancer.
Wang Y; Dong H; Wu H; Zhang L; Yuan K; Chen H; Jiao M; Fu R
BMC Cancer; 2015 May; 15():382. PubMed ID: 25956308
[TBL] [Abstract][Full Text] [Related]
20. Is there a requirement for axillary lymph node dissection following identification of micro-metastasis or isolated tumour cells at sentinel node biopsy for breast cancer?
Joyce DP; Solon JG; Prichard RS; Power C; Hill AD
Surgeon; 2012 Dec; 10(6):326-9. PubMed ID: 22386798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
